...-HF Presented as Late Breaking Science Presentations at the European Society of Cardiology Heart ...
Morningstar· 14 hours agoData from Up to Six Months of Treatment with Aficamten Show Significant and Sustained Reductions in LVOT Gradients with Improvements in Functional Class, Symptoms, and Biomarkers Analyses from ...
BRG1 is a biomarker of hypertrophic cardiomyopathy in human heart specimens - Scientific Reports
Nature· 7 days agoHypertrophic cardiomyopathy (HCM) is a genetic disease of the sarcomere that causes otherwise unexplained cardiac hypertrophy and is associated with sudden ...
Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease...
Journal of the American Medical Association· 2 weeks agoThis genetic association study investigates the association of pathogenic DNA variants implicated in inherited cardiomyopathy with cardiovascular disease outcomes and all-cause mortality.
-$0.26 Earnings Per Share Expected for LianBio (NASDAQ:LIAN) This Quarter
ETF DAILY NEWS· 2 weeks agoEquities research analysts expect that LianBio (NASDAQ:LIAN – Get Rating) will post earnings of ($0.26) per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates ...
May 13 2022 This Week in Cardiology
Medscape· 1 week agoFor more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast on Apple Podcasts, Spotify, or your preferred podcast...
LianBio (NASDAQ:LIAN) Short Interest Update
ETF DAILY NEWS· 1 week agoLianBio (NASDAQ:LIAN – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 2,460,000 shares, an ...
If You Have This Gene, Be Worried About Heart Disease
Eat This, Not That! via Yahoo News· 1 week agoHeart disease is the leading cause of death in the United States for both men and women, according...
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic...
Benzinga· 1 day agoGeoVax Labs, Inc. GOVX was the biggest beneficiary, with its stock more than doubling in the week. NanoViricides, Inc. NNVC also advanced strongly following positive clinical updates provided ...
Tenaya Therapeutics (TNYA) vs. Its Peers Head to Head Contrast
ETF DAILY NEWS· 5 days agoTenaya Therapeutics (NASDAQ:TNYA – Get Rating) is one of 255 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its peers? We will ...
Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update -...
Benzinga· 2 weeks agoTN-201 Received Orphan Medicinal Product Designation from the European Commission Preclinical TN-401 Data Presented at Heart Rhythm 2022 Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission
Yahoo Web Search
Top News Videos for Hypertrophic Cardiomyopathy and Heart Failure
04:59Heart Transplant Recipient Becomes Cardiologist to Help Others
The Doctors CBS via Yahoo News
· 3 weeks agoTrending Now
- 1 Mick Jagger
- 2 Catie Li Model
- 3 Adele
- 4 Olivia Wilde
- 5 Domain Names
